DP018 | HYPOMETHYLATING AGENTS ALONE STILL HAVE A ROLE IN ACUTE MYELOID LEUKEMIA TREATMENT: RESULTS OF A RETROSPECTIVE REAL-LIFE STUDY ON 132 PATIENTS.
Decitabine (DEC) and Azacitidine (AZA) alone or in combination with Venetoclax (VEN) represent the gold standard treatment for unfit patients (pts) with acute myeloid leukemia (AML). As these two strategies differ in terms of efficacy (greater with HMAs-VEN combination) and tolerability (better wit...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Ferrata Storti Foundation
2025-09-01
|
| Colección: | Haematologica |
| Acceso en línea: | https://haematologica.org/article/view/12782 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|